(lp0
S"Arrowhead Pharmaceuticals Inc.  Moves Lower on Volume Spike for April 17 Equities.com - 12 hours ago Arrowhead Pharmaceuticals Inc.  traded on unusually high volume on Apr. 17, as the stock lost 0.63% to close at $1.57.The Analysts Offer Predictions for Arrowhead Pharmaceuticals, Inc.'s FY2017 ... - Petro Global News 24Jefferies Group LLC Reaffirms &quot;Hold&quot; Rating for Arrowhead Pharmaceuticals Inc ... - BNB Daily "
p1
aS"Why Arrowhead Pharmaceuticals Inc. Is Plummeting Today Motley Fool - Nov 9, 2016 Arrowhead stated that the U.S. Food and Drug Administration has verbally notified the company of the agency's decision to place a study called Heparc-2004 on hold.Arrowhead Stock Falls After FDA Places Hold on Clinical Trial - Xconomy"
p2
aS"Here's Why Arrowhead Pharmaceuticals Inc. Is Being Obliterated Today Motley Fool - Nov 30, 2016 It is a rough day to be an investor in Arrowhead Pharmaceuticals . Shares of the clinical-stage biotech are collapsing, falling more than 65% as of 11:36 a.m.Arrowhead Pharmaceuticals halts work on lead hepatitis B drugs, cuts staff - Madison.comArrowhead Pharma sinks after shelving three drug programs - Reuters"
p3
aS"What's Next for Arrowhead Pharmaceuticals, Inc. After the Stock Meltdown? Motley Fool - Nov 10, 2016 Things had been looking pretty good for Arrowhead Pharmaceuticals, Inc.  this year. Not anymore. Shares of the biotech plunged over 30% on Wednesday after the U.S.Chardan Weighs in on Biotech Stocks Novavax, Inc.  and Arrowhead ... - Smarter AnalystArrowhead Pharmaceuticals' Clinical Hold Woes Are Overblown - Seeking Alpha"
p4
aS'Equity Watch: Arrowhead Pharmaceuticals, Inc.  Benton Bulletin - 15 hours ago Arrowhead Pharmaceuticals, Inc.  presently has a Piotroski F-Score of 2. The goal of the F-Score is to help locate companies with strengthening balance sheets, and to weed out poor performers.'
p5
aS'Company Update : Arrowhead Pharmaceuticals Inc Reports FQ1:17 Results Smarter Analyst - Feb 6, 2017 The 12-month average price target assigned to the stock is $2.00, which represents a slight upside potential from current levels. Arrowhead Pharmaceuticals, Inc. engages as a biopharmaceutical company developing targeted RNAi therapeutics. Its pipeline&nbsp;...'
p6
aS'Analyst Opinion on: Arrowhead Pharmaceuticals, Inc.  TRA - 22 hours ago Arrowhead Pharmaceuticals, Inc.  ended its last session at $1.58 by Declining -4.24%. The company currently has an average volume of 768.08 Million.'
p7
aS'Looking at the Levels for Arrowhead Pharmaceuticals, Inc.  BVN - 19 hours ago Taking a closer look at some quality ratios for Arrowhead Pharmaceuticals, Inc. , the firm has a Gross Margin  ratio of 0.031055.'
p8
aS'Arrowhead Pharmaceuticals Inc.  Soars 10.86% on January 31 Equities.com - Jan 31, 2017 Arrowhead Pharmaceuticals Inc.  had a good day on the market for Tuesday January 31 as shares jumped 10.86% to close at $1.94.'
p9
aS'Analysts Set Arrowhead Pharmaceuticals Inc  Target Price at $2.81 The Cerbat Gem - Apr 15, 2017 Arrowhead Pharmaceuticals logo Shares of Arrowhead Pharmaceuticals Inc  have been assigned a consensus recommendation of Hold from the six analysts that are presently covering the company.-$0.12 EPS Expected for Arrowhead Pharmaceuticals Inc  This Quarter - Chaffey Breeze'
p10
a.